News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Taligen Therapeutics Announces Key Additions to Management Team



4/15/2010 10:08:47 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has strengthened its management team with the addition of Sven Ante (Bill) Lundberg, MD as Chief Medical Officer and Karen Tubridy, PharmD, as Vice President, Clinical Operations and Regulatory Affairs.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES